Annovis Bio - Buntanetap - the share price is down and I wonder why?

[PDTom]

Annovis Bio - Buntanetap - the share price is down and I wonder why?

There are conflicting reports about trial participants in phase 3 and also financially Annovis Bio is a bit weak, but such a bad share price?

Maybe this means that "Buntanetap" will not make it through the phase 3 trial successfully after all. Often the "insiders" know more. And with such a small company...

What do you think?

I still have very high hopes for a successful phase 3, as it would be a very interesting drug without major side effects.

From my point of view the most interesting at the moment!

[Farooqji]

I have come across comments from only few people who have felt a positive effect

[tacato in reply to Farooqji]

I’m one of them.

[emstadler71 in reply to tacato]

Me too! Really hoping they will open label extension. I can feel the difference after going off in July.

[tacato in reply to emstadler71]

I agree with both points (I also went off in July). For the first four months of the study, I generally declined month over month. But for the last two months of the stud three of the four symptoms that I evaluated improved.

[emstadler71 in reply to tacato]

It definitely was not an immediate effect but within 2-3 months I felt so much better and had an arm swing again!! And zero off time while on it!! Fingers crossed 🤞

[MBAnderson]

prospective investors are reading early anecdotes

[park_bear]

ANVS tracks the NASDAQ Jr biotech index, Except for news related spikes

ANVS tracks the NASDAQ Jr biotech index

[fido2]

I found this article interesting: clinicaltrialsarena.com/com...